Biocontrol To Spin Out IDT Subsidiary In IPO To Develop Hyperthermia System
This article was originally published in The Gray Sheet
Executive Summary
Biocontrol Technology plans to spin out a minority stake in its IDT, Inc. subsidiary to raise funds for the development of the ThermoChem system for perfusion-induced hyperthermia.